Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3- Arabinoxylane) and targeted radiofrequency heat therapy POPARTE BADANIAMI

  • Gabriel Petrovics, Gyula Szigeti, Szilárd Hamvas, Ágnes Máté, József Betlehem, Gabriella Hegyi*
  • (edited by Chris Gutch PhD.)
  • 2016

Introduction: Although modern therapies for cancer have improved life expectancy, the management of

disease and improvement of quality of life (QoL) of patients, especially managing cancer-related pain and

chronic fatigue syndrome are still limited. We demonstrate the efficacy of a combined therapy to treat cancer

patients suffering from CFS. The effects of a combined therapy in cancer patients suffering from CFS was

evaluated. NK cells were stimulated, additional tumour treatment together with targeted radiofrequency

therapy (Oncothermia).

Methods: SIXTY patients with CFS (due to suffering from any type of cancer) were recruited, (according to

the Centres for Disease Control 1994 criteria) attending an outpatient specialist CFS service for controlled

pilot study. A total of 25 participants were given oral BioBran (MGN-3-Arabinoxylane), + Oncothermia, for

six months, equivalent control group has not received this complex (BioBran + Oncothermia) treatment,

they received chemo-,radiotherapy treatment.

Results: The whole body pH status showed strong tissue acidity before the treatment, but the BioBran

group changed the tissue pH status. The most important finding was that the average of CFQ score was

significantly reduced after the treatment, and in control group the CFQ scores did not change

significantly.

Conclusion: The findings support a specific therapeutic effect of the complex BioBran+ Oncothermia

therapy in CFS of cancer patients improving their QoL, enhancing NK activity in synergy.

© 2016 Published by Elsevier GmbH.

We use cookies to improve your experience on our website. For more details see our cookie policy.

Like many other websites, we use cookies to provide enhanced functionality and track the usage of our websites with Google Analytics, and some of our third-party advertisers might use them to deliver adverts tailored to what they think you might be interested in.

What are cookies?

Cookies are small text files which can be sent to browser when you visit websites and saved to your device (computer or other device with Internet access, i.e. smartphone or tablet). Cookies are saved in the folder for files of your browser. Cookies usually contain the name of the website they come from and the date of origin. Upon your next visit the browser loads cookies again and sends these information back to the website which originally created cookies. Cookies we use do not harm your computer.

Using cookies

By using this website you give your consent to using cookies in compliance with your browser settings. If you visit our websites, acceptance of cookies is allowed in your browser, you do not change your browser settings and continue visiting our websites we consider it as accepting our conditions for using cookies.

Why are we using cookies?

Cookies are used to optimally create and constantly improve the quality of our services, adjust them to your interests and needs and improve their structure and contents. We do not use data obtained by using cookies to contact users by mail, e-mail or telephone.

How to change settings of cookies?

Majority of browsers have been originally set to automatically accept cookies. This settings can be changed by blocking cookies or by a notification in case cookies are to be sent to your device. Instructions for changing cookies are available in the option “Help” of every browser. If you use different devices to access websites (e.g. computer, smartphone, tablet), we recommend you to adjust every browser on each of them to your preferences regarding cookies.

Why to keep settings of cookies?

Using cookies and permitting cookies in your browser is your decision. However, in case you change settings of cookies, functionality of some of our websites can be limited and their user comfort reduced.